NEW YORK (Genomeweb) – Everything Genetic will distribute and market OncoDNA's solutions in the UK under an agreement announced today.

All of OncoDNA's services are now available for clinical use, it said, adding oncologists and patients will be able to access its molecular profiling solutions that combine liquid and solid biopsy assays. 

Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.